Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04085302 · ClinicalTrials.gov registry record · NA
TARA Working Prototype Engagement Evaluation: Feasibility Study
A NA study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04085302 is a NA study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 16 participants.
The verdict
NCT04085302, a NA study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
TARA is a Digital Behaviour Change Intervention (DBCI) for individuals with Chronic Obstructive Pulmonary Disease (COPD)(IwCOPD), which has been designed using a Human-Centred Design (HCD) methodology. HCD involves, among other elements, members of the target audience in evaluations at multiple stages within the design process. This feasibility study is primarily designed to assess the acceptability of the DBCI test asset to the target audience. Acceptability as defined for the purpose of this study includes usability of the system, and perceived value and desirability to the end-user audience. As such, engagement in this context is deemed to mean the degree to which the test asset provides a usable, acceptable, desirable and valuable experience to its users during a time-limited trial.
Interventions
- DEVICE Digital Behaviour Change Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2019-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04085302
The ClinicalTrials.gov registry entry for NCT04085302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital Behaviour Change Intervention is the first listed.
NCT04085302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04085302 about?
NCT04085302 is a clinical study titled "TARA Working Prototype Engagement Evaluation: Feasibility Study". TARA is a Digital Behaviour Change Intervention (DBCI) for individuals with Chronic Obstructive Pulmonary Disease (COPD)(IwCOPD), which has been designed using a Human-Centred Design (HCD) methodology. HCD involves, among other elements, members of the target audience in evaluations at multiple stag...
What is the current status of trial NCT04085302?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-09-26. Estimated completion is 2019-12-03.
What interventions are being tested in trial NCT04085302?
The interventions under investigation include: Digital Behaviour Change Intervention (DEVICE).
Who is sponsoring clinical trial NCT04085302?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.